Taspoglutide

Taspoglutide is a pharmaceutical drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Roche.

Online Inquiry

Specification Technical Data Related Products Featured Products Customer reviews and Q&A Useful Tools Publications

CAT#	10-101-176
CAS	275371-94-3
Synonyms/Alias	UNII-2PHK27IP3B
M.F/Formula	C152H232N40O45
M.W/Mr.	3339.70948
Sequence	H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Aib-Arg-NH2
Labeling Target	Glucagon-like peptide 1 (GLP-1) receptor
Application	Taspoglutide is developed for treatment of type 2 diabetes
Activity	Agonist
Areas of Interest	Metabolic Disease
Disease	Type 2 diabetes

CAT#	Product Name	Inquiry
10-101-311	α-MSH (11-13) (free acid)	Inquiry
10-101-206	Antagonist G	Inquiry
HB00091	ACTH (1-39), PORCINE	Inquiry
10-101-254	Dnp-Pro-Leu-Gly-Leu-Trp-Ala-DArg-NH2	Inquiry
10-101-312	PE22-28	Inquiry

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-20	Goserelin Acetate	1269.43	C59H84N18O14	Inquiry
10-101-59	Liraglutide	3751.2	C172H265N43O51	Inquiry
R1574	Octreotide	1019.24	C₄₉H₆₆N₁₀O₁₀S₂	Inquiry
10-101-139	Myrcludex B			Inquiry
10-101-285	Teduglutide	3752.08	C164H252N44O55S	Inquiry
R1847	Sermaglutide	4114	C187H291N45O59	Inquiry
R1961	Carbetocin	988.2	C45H69N11O12S	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Source#	Synthetic
Storage	-20°C
BoilingPoint	N/A
Melting Point	N/A